Ma, Yihui – Trademark Portfolio

Entity Type: 01

Ma, Yihui holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 24 (Fabrics) across 3 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include FITFORGE, HEALTHYEA, and NOVANUTRI. The owner is based in Hebei Province.

Jianchapu Town, Bazhou City

No. 077, East 2nd Street

Hebei Province 065700 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Ma, Yihui's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

24
Fabrics (1 filing)

Textiles and textile goods; bed covers; table covers

8
Hand Tools (1 filing)

Hand tools and implements (hand-operated); cutlery; side arms; razors

Frequently Asked Questions

How many trademarks does Ma, Yihui have?

Ma, Yihui has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.

What trademark classes does Ma, Yihui file in?

Ma, Yihui files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 24 (Fabrics), Class 8 (Hand Tools). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Ma, Yihui's most well-known trademarks?

Ma, Yihui's registered trademark portfolio includes well-known marks such as FITFORGE, HEALTHYEA, and NOVANUTRI. These are among 3 currently registered trademarks in the portfolio.

What is Ma, Yihui's trademark registration success rate?

Ma, Yihui has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.